Blood test shows high accuracy in detecting stage I non-small cell lung cancer

BACKGROUND: In a previous study (Goebel et. al, Cancer Genomics Proteomics 16:229-244, 2019), we identified 33 biomarkers for an early stage (I-II) Non-Small Cell Lung Cancer (NSCLC) test with 90% accuracy, 80.3% sensitivity, and 95.4% specificity. For the current study, we used a narrowed ensemble...

Descripción completa

Detalles Bibliográficos
Autores principales: Goebel, Cherylle, Louden, Christopher L., Mckenna, Robert, Onugha, Osita, Wachtel, Andrew, Long, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035746/
https://www.ncbi.nlm.nih.gov/pubmed/32085733
http://dx.doi.org/10.1186/s12885-020-6625-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035746/
https://www.ncbi.nlm.nih.gov/pubmed/32085733
http://dx.doi.org/10.1186/s12885-020-6625-x

Ejemplares similares